Basic Information
ID: ALA4222649
Type: Functional
Description: Antiviral activity against HIV1 harboring reverse transcriptase F227L/V106A double mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay
Organism: Human immunodeficiency virus 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4222649
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 267.24 | -0.20 | -0.20 |
| 435.29 | 4.72 | 4.72 |
| 315.68 | 4.07 | 4.07 |
| 507.64 | 5.30 | 5.30 |
| 421.50 | 6.24 | 6.24 |
| 435.49 | 5.36 | 5.36 |
| 453.55 | 5.01 | 5.01 |
| 440.51 | 5.10 | 5.10 |
| 422.49 | 5.64 | 5.64 |
| 494.60 | 5.39 | 5.39 |
| 494.60 | 4.35 | 4.35 |
| 400.87 | 6.30 | 6.30 |
| 466.55 | 5.63 | 5.63 |
| 422.49 | 5.61 | 5.61 |
| 508.63 | 5.78 | 5.78 |
| 456.51 | 5.03 | 5.03 |
| 421.50 | 6.22 | 6.22 |
| 401.86 | 5.69 | 5.69 |
| 439.52 | 5.70 | 5.70 |
| 465.56 | 6.23 | 6.23 |
| 495.59 | 4.78 | 4.78 |
| 452.56 | 5.62 | 5.62 |